• Je něco špatně v tomto záznamu ?

Synthesis of novel quinoline-thiazolobenzimidazolone hybrids as anticancer agents through caspase-dependent apoptosis

H. Bouria, H. Alliouche, MI. Chouiter, A. Belfaitah, T. Pacheco, V. Gala, D. Pereira, AMS. Silva

. 2025 ; 17 (5) : 543-555. [pub] 20250226

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25009624

AIM: This work explores the synthesis of new bi-heterocyclic hybrid compounds based on quinoline ring and investigates their potential as anticancer agents. MATERIALS & METHODS: The novel fused quinoline-thiazolo[3,2-a] benzimidazole-3(2 h)one hybrids were prepared by regioselective nucleophilic ring opening of the corresponding quinolinyl-oxiranes. In vitro cytotoxic activity was evaluated against human lung (A549) and gastric (AGS) cancer cell lines. RESULTS: Global results showed that all tested compounds have promising inhibitory properties. Compounds 17 and 18 bearing two methoxy groups on the quinoline ring have exhibited remarkable and interesting activities. The investigation of the cell death process showed that these compounds activated a caspase-dependent apoptosis pathway. Results were further supported by molecular docking studies. CONCLUSION: Both compounds exhibited good drug-like characteristics, which make them promising drug candidates.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25009624
003      
CZ-PrNML
005      
20250429135233.0
007      
ta
008      
250415s2025 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1080/17568919.2025.2470112 $2 doi
035    __
$a (PubMed)40008604
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Bouria, Houria $u Equipe de Synthèse de Molécules à Objectif Thérapeutique (SMOTH), Laboratoire des Produits Naturels d'Origine Végétale et de Synthèse Organique. Faculté des Sciences Exactes, Campus de Chaabat Ersas, Université Frères Mentouri-Constantine1, Constantine, Algeria
245    10
$a Synthesis of novel quinoline-thiazolobenzimidazolone hybrids as anticancer agents through caspase-dependent apoptosis / $c H. Bouria, H. Alliouche, MI. Chouiter, A. Belfaitah, T. Pacheco, V. Gala, D. Pereira, AMS. Silva
520    9_
$a AIM: This work explores the synthesis of new bi-heterocyclic hybrid compounds based on quinoline ring and investigates their potential as anticancer agents. MATERIALS & METHODS: The novel fused quinoline-thiazolo[3,2-a] benzimidazole-3(2 h)one hybrids were prepared by regioselective nucleophilic ring opening of the corresponding quinolinyl-oxiranes. In vitro cytotoxic activity was evaluated against human lung (A549) and gastric (AGS) cancer cell lines. RESULTS: Global results showed that all tested compounds have promising inhibitory properties. Compounds 17 and 18 bearing two methoxy groups on the quinoline ring have exhibited remarkable and interesting activities. The investigation of the cell death process showed that these compounds activated a caspase-dependent apoptosis pathway. Results were further supported by molecular docking studies. CONCLUSION: Both compounds exhibited good drug-like characteristics, which make them promising drug candidates.
650    _2
$a lidé $7 D006801
650    12
$a protinádorové látky $x farmakologie $x chemie $x chemická syntéza $7 D000970
650    12
$a apoptóza $x účinky léků $7 D017209
650    12
$a chinoliny $x chemie $x farmakologie $x chemická syntéza $7 D011804
650    12
$a benzimidazoly $x farmakologie $x chemie $x chemická syntéza $7 D001562
650    12
$a simulace molekulového dockingu $7 D062105
650    12
$a kaspasy $x metabolismus $7 D020169
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a screeningové testy protinádorových léčiv $7 D004354
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
650    _2
$a molekulární struktura $7 D015394
650    _2
$a thiazoly $x chemie $x farmakologie $x chemická syntéza $7 D013844
650    _2
$a proliferace buněk $x účinky léků $7 D049109
655    _2
$a časopisecké články $7 D016428
700    1_
$a Alliouche, Hayette $u Equipe de Synthèse de Molécules à Objectif Thérapeutique (SMOTH), Laboratoire des Produits Naturels d'Origine Végétale et de Synthèse Organique. Faculté des Sciences Exactes, Campus de Chaabat Ersas, Université Frères Mentouri-Constantine1, Constantine, Algeria $1 https://orcid.org/0000000341350229
700    1_
$a Chouiter, Mohamed Imed $u Equipe de Synthèse de Molécules à Objectif Thérapeutique (SMOTH), Laboratoire des Produits Naturels d'Origine Végétale et de Synthèse Organique. Faculté des Sciences Exactes, Campus de Chaabat Ersas, Université Frères Mentouri-Constantine1, Constantine, Algeria
700    1_
$a Belfaitah, Ali $u Equipe de Synthèse de Molécules à Objectif Thérapeutique (SMOTH), Laboratoire des Produits Naturels d'Origine Végétale et de Synthèse Organique. Faculté des Sciences Exactes, Campus de Chaabat Ersas, Université Frères Mentouri-Constantine1, Constantine, Algeria
700    1_
$a Pacheco, Teresa $u REQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal
700    1_
$a Gala, Viktor $u REQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal $u Faculty of Pharmacy, Charles University, Hradec Králové, Czech Republic
700    1_
$a Pereira, David $u REQUIMTE/LAQV, Laboratório de Farmacognosia, Departamento de Química, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal
700    1_
$a Silva, Artur M S $u LAQV-REQUIMTE & Department of Chemistry, University of Aveiro, Aveiro, Portugal
773    0_
$w MED00180228 $t Future medicinal chemistry $x 1756-8927 $g Roč. 17, č. 5 (2025), s. 543-555
856    41
$u https://pubmed.ncbi.nlm.nih.gov/40008604 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250415 $b ABA008
991    __
$a 20250429135229 $b ABA008
999    __
$a ok $b bmc $g 2311163 $s 1246705
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2025 $b 17 $c 5 $d 543-555 $e 20250226 $i 1756-8927 $m Future medicinal chemistry $n Future Med Chem $x MED00180228
LZP    __
$a Pubmed-20250415

Najít záznam

Citační ukazatele

Možnosti archivace